---
$id: https://graph.org.ai/products/commodity/51144124
$type: Product
source: UNSPSC
code: "51144124"
title: "Lisdexamfetamine"
class: "51144100"
classTitle: "Stimulant or anorexiant amphetamines"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lisdexamfetamine

**UNSPSC Code**: 51144124
**Class**: [Stimulant or anorexiant amphetamines](Stimulant or anorexiant amphetamines.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anorexiant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) H645GUL8KJ. European Medicines Agency schedules Lisdexamfetamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32170. Lisdexamfetamine generally arises in the molecular formula C15H25N3O. The term LISDEXAMFETAMINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 20, no. 3, 2006, list 56.) Most nations, for tariff and trade purposes, schedule lisdexamfetamine under HS 29242990 and SITC 51479. As of Q4 2014, LISDEXAMFETAMINE remains US FDA's Preferred Term for this commodity. Lisdexamfetamine bears US NLM identifiers UMLS ID C1873633 and NCI Concept Code C75114. SMILES: CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N.

